Beta
393364

Systemic Corticosteroids with or without Nebulized Budesonide for Treatment of Acute Severe Asthma Exacerbations in the Emergency Room: A retrospective Study

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

Internal Medicine

Abstract

Background: Acute severe asthma exacerbations remains a treatment challenge. The value of inhaled added to systemic corticosteroids in the treatment of acute severe asthma is not well addressed.
The Aim of the Work: This study aimed to investigate the value of inhaled corticosteroids added to systemic corticosteroids compared to systemic corticosteroids alone in the management of acute severe asthma exacerbation treated in emergency room..
Patients and Methods: 115 patients were included and divided into study (n = 55) included patients received inhaled hydrocortisone 100 mg IV, nebulized ipratropium bromide 500µg , Salbutamol 0.5 % respiratory solution and budesonide 0.5 mg at 20-, 40-, 60- and 120-min; and the comparison (n= 60) group received the standard protocol only.  The following data were documented: Respiratory rate, heart rate, blood pressure, peak expiratory flow rate, were documented over 3 hours after initiation of treatment. The Primary outcome was improvement of PEF and the admission rate. 
Results: The basal PEF (L/min) ranged between 120 and 210, with no significant differences. There was progressive reduction of PEF overtime in both groups. However, the percentage of reduction was significantly higher in the study than the comparison groups (99.86±16.64 vs  89.52±22.25, respectively). The difference between groups was significant at 120 to 180 minutes. Respiratory rate was significantly and progressively reduced in both the study and the comparison groups at the end of assessment than the basal values. The percentage of reduction was significantly higher among the study than the comparison groups (38.22±4.20 vs 36.21±4.14, respectively, p = 0.011). The study and comparison groups showed non-significant differences, as hospitalization was recorded for 29.1% and 35.0% of the study and the comparison groups respectively.
Conclusion: The association of nebulized budesonide with systemic corticosteroids provides mild additional effects than systemic corticosteroids alone for severe asthma in emergency department.

DOI

10.21608/ijma.2024.333093.2063

Keywords

bronchial asthma, Corticosteroids, Inhalers, The peak expiratory flow

Authors

First Name

Mokhles

Last Name

Zineldin

MiddleName

Abdelfadil Ibrahim

Affiliation

Department of Chest Diseases, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.

Email

mokhlesabdelfadil@gmail.com

City

Damietta

Orcid

-

First Name

Sayed Abd elsabour

Last Name

Kinawy

MiddleName

-

Affiliation

Chest Diseases Department, Faculty of Medicine, Aswan University, Aswan, Egypt , Intensive Care Unit, New Najran General Hospital, KSA.

Email

sayed_chest@yahoo.com

City

-

Orcid

-

Volume

6

Article Issue

11

Related Issue

52126

Issue Date

2024-11-01

Receive Date

2024-11-02

Publish Date

2024-11-01

Page Start

5,116

Page End

5,121

Print ISSN

2636-4174

Online ISSN

2682-3780

Link

https://ijma.journals.ekb.eg/article_393364.html

Detail API

https://ijma.journals.ekb.eg/service?article_code=393364

Order

11

Type

Original Article

Type Code

816

Publication Type

Journal

Publication Title

International Journal of Medical Arts

Publication Link

https://ijma.journals.ekb.eg/

MainTitle

Systemic Corticosteroids with or without Nebulized Budesonide for Treatment of Acute Severe Asthma Exacerbations in the Emergency Room: A retrospective Study

Details

Type

Article

Created At

24 Dec 2024